Ryan David Lake - 18 Jan 2022 Form 4 Insider Report for Recro Pharma, Inc.

Signature
By: Ryan D. Lake
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
-$1,805
Form type
4
Filing time
19 Jan 2022, 15:31:12 UTC
Previous filing
04 Jan 2022
Next filing
24 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability $1,805 -1,094 -0.32% $1.65 337,892 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.